Gene Query: NOTCH3

Dataset Description Geneva Score
Rorc disruption in human FG pancreatic cancer cells 118.68
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 108.11
BCL11B 97.81
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 95.94
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 82.71
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 73.54
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 71.39
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 71.39
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 71.0
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 68.05
Transcriptome analysis in Neobractatin treated cells 67.22
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 66.29
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 63.81
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 62.73
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 61.72
RNA-seq analyisis of PUM2 knockout cells 57.52
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 56.02
Genome-wide analysis of Dengue virus 2 infected cells 55.65
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 52.93
MCF10A H-Ras RNA-Seq 52.76
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 52.1
Generation of trichogenic adipose-derived stem cells by expression of three factors 51.97
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 51.94
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 51.63
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 51.11
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 50.28
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 48.9
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 47.87
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 46.36
Studying the selectivity of a small molecule Synucleozid on transcriptome 46.22
A role for ZNF598 in post-transcriptional gene regulation 45.8
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 45.79
RNA-seq of human fibroblasts after irradiation 45.76
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 45.04
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 44.01
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 42.86
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 42.45
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 42.18
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 41.95
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 41.67
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 39.83
RNA sequencing of BT142 and TS603 cell lines 39.83
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 39.72
RNA-seq in transgenic cells 39.57
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 38.92
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 38.92
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 38.65
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 38.64
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 37.87
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 37.64
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 37.49
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 37.29
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 37.1
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 37.1
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 37.04
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 35.75
RNA expression following TMPRSS11B overexpression or depletion 34.64
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 34.6
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 34.34
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 34.33
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 34.25
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 34.25
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 34.25
Transcriptome analyses of human pancreatic islets and pseudoislets 34.21
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 33.37
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 32.96
AMPK signaling for naïve pluripotency 32.78
AMPK signaling for naïve pluripotency [Hs] 32.78
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 32.78
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 32.78
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 32.74
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 32.31
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 31.78
RNA-Seq analysis of breast cancer cells after shikonin treatment 31.54
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 31.42
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 31.3
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 31.24
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 30.95
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 30.95
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 30.85
LncRNA-GAS5 negative regulation of YAP-target genes expression 30.76
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 30.15
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 30.13
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 30.13
RNA-seq of human aneuploid cell lines with Trisomy 21 30.12
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 30.02
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 30.01
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 29.6
SOX11 knockdown in B-ALL cell lines 29.55
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 29.48
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 29.44
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 29.44
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 29.32
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 28.77
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 28.58
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 28.54
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 28.49
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 28.48
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 28.19
CHD1 regulates cell fate determination by activation of differentiation-induced genes 28.0
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 27.87
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 27.87
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 27.83
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 27.68
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 27.68
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 27.61
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 27.56
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 27.24
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 27.22
HNRNPL and its RNA Targets in Prostate Cancer 27.2
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 27.2
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 27.17
ETV7 and interferon response 27.17
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 27.17
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 27.04
Modeling Familial Cancer with iPSC Approaches 27.0
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 27.0
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 26.85
Differentially expressed vascular development genes for iPSC-ECs from CDI 26.79
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 26.77
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 26.68
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 26.65
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 26.61
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 26.45
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 26.29
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 26.23
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 26.01
Characterization of the Merkel cell carcinoma miRNome 26.0
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 25.35
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 25.35
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 25.35
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 25.25
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 25.25
Gene expression profile in breast cancer cell lines using RNA sequencing 24.96
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 24.95
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 24.88
Silencing SPIB in attached and floating state of H1703 lung cancer cells 24.86
Total RNA-seq in ALL-SIL upon JQ1 inhibition 24.72
DJ-1 is dispensable for human stem cell homeostasis 24.68
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 24.63
A sister of NANOG regulates genes expressed in pre-implantation human development 24.41
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 24.24
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 24.19
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 24.19
Identification of Nrf2 regulated genes by RNA sequencing 24.14
Nrf2 regulated genes in A549 cells 24.14
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 24.05
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 23.99
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 23.72
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 23.59
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 23.5
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 23.5
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 23.46
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 23.41
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 23.36
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 23.31
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 23.2
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 23.2
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 23.01
Global gene expression profile of dasatinib-resistant RCH-ACV cells 22.88
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 22.57
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 22.38
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 22.27
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 22.26
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 22.26
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 22.2
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 22.19
RNA-seq of young and quiescent MRC-5 human fibroblasts 22.06
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 22.04
snRNAs as regulators of alternative splicing 21.98
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 21.84
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 21.83
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 21.8
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 21.76
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 21.7
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 21.6
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 21.57
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 21.43
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 21.43
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 21.42
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 21.39
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 21.19
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 21.17
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 21.12
Transcriptomic profile of human embryonic renal corpuscles 20.99
SETBP1-WT and SETBP1-G870S epigenetic landscapes 20.93
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 20.93
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 20.81
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 20.75
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 20.69
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 20.68
Inhibition of TNBC metastasis by Gpx1 20.68
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 20.61
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 20.57
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 20.57
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 20.57
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 20.54
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 20.25
A549 cells and MSR-A549 cells 20.25
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 20.19
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 20.18
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 20.17
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 20.12
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 20.11
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 20.11
Aortic Valve Tissue: Stenosis vs. Sclerosis 20.1
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 19.98
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 19.82
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 19.76
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 19.73
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 19.68
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 19.67
Total RNA sequencing of APC mutant and wt colonic organoids 19.54
Differential Gene Expression between MCF10A and MCF7 cells 19.5
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 19.48
RNA-seq analysis of uveal melanoma cells treated with FR900359 19.39
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 19.26
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 19.26
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 19.26
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 19.25
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 19.18
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 19.1
Nutritional control of protein translation 19.06
Identifying the molecular mode of action of itraconazole in colorectal cancer 19.02
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 18.96
RNA-sequencing of human tendon after injury 18.95
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 18.93
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 18.93
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 18.92
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 18.87
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 18.82
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 18.66
Effect of disulfiram treatment on pediatric high grade glioma 18.56
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 18.53
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 18.51
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 18.48
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 18.48
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 18.42
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 18.12
H1609088 Human RNA-Sequencing 18.07
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 18.0
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 17.98
RNA Sequencing of three pairs of gastric cancer 17.97
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 17.96
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 17.8
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 17.73
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 17.72
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 17.72
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 17.72
17.68
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 17.63
An acquired vulnerability of drug resistant melanoma with therapeutic potential 17.6
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 17.6
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 17.55
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 17.53
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 17.35
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 17.34
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 17.34
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 17.34
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 17.32
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 17.28
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 17.25
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 17.25
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 17.22
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 17.22
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 16.94
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 16.93
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 16.93
Functional role of SLIT2 and ROBO1 in trophoblasts 16.9
RNA-seq of MCF10A cells and CAF 16.87
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 16.78
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 16.76
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 16.76
The age and genomic integrity of neurons after cortical stroke in humans 16.65
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 16.61
METTL3 promotes translation in human cancer cells 16.56
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 16.54
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 16.51
RNA-seq analysis to identify the genes regulated by p53-SET interplay 16.45
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 16.33
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 16.33
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 16.28
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 16.16
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 16.16
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 15.97
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 15.97
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 15.87
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 15.8
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 15.62
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 15.54
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 15.54
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 15.41
Dynamic 3D chromosomal landscapes in acute leukemia 15.41
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 15.32
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 15.27
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 15.14
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 15.13
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 15.04
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 14.84
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 14.75
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 14.73
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 14.71
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 14.7
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 14.7
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 14.7
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 14.63
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 14.63
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 14.58
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 14.32
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 14.29
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 14.26
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 14.12
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 14.08
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 14.06
Downregulation of DDX5/DDX17 and REST 14.01
A novel target of EZH1/2 for treatment of mantle cell lymphoma 13.93
SF3B1 Degron knockdown RNA-seq 13.91
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 13.89
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 13.85
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 13.84
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 13.84
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 13.61
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 13.58
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 13.54
circRNA-sequencing 13.26
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 13.1
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 13.08
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 13.06
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 13.06
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 13.02
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 13.01
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 12.94
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 12.89
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 12.86
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 12.85
RNA sequencing of T-ALL (COG study) 12.84
Analyses of T-ALL (COG study) 12.84
Morphological and molecular characterization of human dermal lymphatic collectors 12.83
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 12.8
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 12.69
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 12.62
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 12.6
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 12.58
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 12.55
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 12.43
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 12.43
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 12.33
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 12.27
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 12.22
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 12.22
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 12.16
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 12.1
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 12.09
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 12.09
Trascriptome of thyroid cancer-induced macrophages 12.08
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 11.98
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 11.91
ARID1A and ARID1B loss in HCT116 and TOV21G cells 11.74
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 11.66
iPSC-Derived Cholangiocytes 11.46
FGF2 regulation of gene expression in stable inducible Neurons 11.42
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 11.31
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 11.27
RNA m5C Methylation in breast cancer using MeRIP-Seq 11.26
Effect of nuclear IL-33 on gene expression 11.23
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 11.13
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 10.98
Searching for target genes of miR-508/509/506/514 in HCT116 cells 10.78
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 10.77
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 10.62
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 10.43
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 10.41
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 10.41
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 10.38
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 10.38
RNA-seq melanoma 10.32
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 10.16
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 9.93
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 9.84
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 9.59
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 9.25
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 9.23
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  8.89
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 8.87
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 8.84
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 8.8
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 8.78
RNA-seq of cancer cell lines treated with T-025 8.77
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 8.77
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 8.77
The comparison of high-throughput single-cell RNA-seq methods 8.75
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 8.71
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 8.68
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 8.66
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 8.66
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 8.62
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 8.47
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 8.46
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 8.37
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 8.21
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 8.17
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 8.14
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 8.14
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 7.79
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 7.78
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 7.74
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 7.74
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 7.7
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 7.68
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 7.67
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 7.66
Investigate A2M treatment on human prostate cancer and mouse liver 7.59
Investigate A2M treatment on human prostate cancer xenograft in mice 7.59
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 7.41
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 7.31
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 7.22
EGR1-controlled transcriptome of T HESCs 7.21
CSL RNA-Seq on HKC and SCC cell lines 7.07
CSL 7.07
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 7.04
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 7.0
Global transcriptome analysis of WT versus HEB-/- hESCs 6.98
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 6.86
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 6.52
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 6.14
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 6.12
RNA splicing alteration on glioblastoma and normal neural stem cells 6.02
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 6.02
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 5.98
TFAP2C signalling in human fibroblasts 5.94
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 5.88
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 5.7
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 5.65
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 5.57
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 5.56
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 5.5
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 5.48
Gene expression analysis in response to hypoxic pathway inhibition 5.46
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 5.08
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 5.0
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 4.89
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 4.89
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 4.81
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 4.76
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 4.43
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 4.28
RNA sequencing of human pancreatic cancer cell lines 4.1
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 4.06
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 3.81
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 3.71
Identification of long noncoding RNAs in T-ALL cell lines 3.58
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 3.55
CHCHD10 gene KO effect in iPSC drived motor neurons 3.37
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 3.24
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 3.16
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 3.08
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 3.08
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 2.95
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 2.94
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 2.86
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 2.81
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 2.8
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 2.8
Deep RNA sequencing of the human placental transcriptome 2.67
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 2.64
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 2.59
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 2.59
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 2.57
The DPYSL2 gene connects mTOR and schizophrenia 2.5
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 2.44
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 2.44
Total RNA-seq in ALL-SIL upon TLX1 knockdown 2.4
Leucegene: ALL sequencing 2.15
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 1.99
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 1.97
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.97
Gene expression regulated by CSA and CSB in neuroblastoma cell line 1.86
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 1.82
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 1.59
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 1.53
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 1.35
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 1.3
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 1.21
RNA expression profiles comparing primary and omental ovarian carcinoma samples 1.15
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.13
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 1.0
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.91
Oncogenic roles of ARID5B in T-ALL 0.91
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 0.89
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.86
BMS-470539 on human synovial fibroblasts 0.77
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 0.74
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 0.67
RNA seq_PDX2_SHP099 0.58
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.23
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 0.14
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 0.13
Gene expression analysis of breast cancer cell-lines 0.01
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.01
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation